Medicine:Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine
From HandWiki
Revision as of 12:23, 23 September 2021 by imported>Rjetedi (linkage)
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Protein subunit |
| Clinical data | |
| Routes of administration | Intramuscular |
Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by Zhongyianke Biotech, Liaoning Maokangyuan Biotech, and Academy of Military Medical Sciences.[1][2]
References
- ↑ "Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04636333.
- ↑ "Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04813562.
 |
